모기 기피제 시장 : 형태별, 원재료별, 적용 방법별, 유통 채널별 - 세계 예측(2026-2032년)

The Mosquito Repellent Market was valued at USD 8.22 billion in 2025 and is projected to grow to USD 8.71 billion in 2026, with a CAGR of 6.16%, reaching USD 12.50 billion by 2032.

A strategic introduction that frames how consumer preferences, regulatory influences, and innovation imperatives are reshaping mosquito repellent product strategies and performance expectations

The mosquito repellent landscape sits at the intersection of public health priorities, consumer lifestyle shifts, and rapid product innovation. Rising awareness of vector-borne diseases continues to shape household and institutional purchasing behavior, while preferences for formulations and ingredient origins evolve alongside changing perceptions of safety and efficacy. Consequently, manufacturers, retailers, and healthcare stakeholders are re-evaluating product portfolios, marketing narratives, and supply chain resilience to meet diverse consumer needs and regulatory expectations.

In parallel, the market is seeing a pronounced move toward differentiated product experiences-beyond simple protection metrics-where sensory attributes, convenience of use, and perceived naturalness influence repeat purchase. This intensifying focus on user experience drives innovation across application formats and delivery systems, prompting collaborations between chemistry specialists, botanicals suppliers, and consumer-packaged-goods brands to create offerings that balance performance with acceptability.

Moreover, regulatory frameworks and public health advisories continue to inform product claims and labeling, which in turn impact communication strategies and product development roadmaps. As stakeholders navigate these dynamics, they must reconcile short-term commercial objectives with longer-term commitments to safety, environmental stewardship, and transparent communication. This introduction frames the core tensions and opportunities that underpin strategic decision-making in a complex, rapidly evolving category.

How product innovation, dual-track consumer preferences, and omnichannel distribution are driving structural change and new competitive paradigms in the mosquito repellent ecosystem

The landscape for mosquito repellents is undergoing transformative shifts driven by advancements in formulation science, growing consumer demand for differentiated experiences, and a reconfiguration of distribution models. Innovation has moved beyond traditional active ingredients to encompass delivery systems that enhance persistence, improve sensory profiles, and integrate with everyday routines. As a result, product differentiation now hinges on the ability to combine proven efficacy with attributes such as scent-neutral formulations, long-lasting protection, and convenient application formats that align with on-the-go lifestyles.

Simultaneously, the consumer mindset is fragmenting along lines of risk perception and ingredient preference. A sizable cohort prioritizes botanical or plant-origin claims, seeking solutions perceived as gentler for repeated use, while another segment continues to value established chemical actives for their track record in efficacy. This dual preference creates an imperative for brands to offer clear, science-backed narratives that address both performance and safety without alienating either cohort. Consequently, transparent communication and third-party validation are becoming central to brand trust.

Distribution channels are adapting to new purchasing behaviors, with omnichannel strategies that blend the immediacy of offline retail with the personalization and convenience of online platforms. This shift facilitates tailored marketing approaches, such as subscription services for high-frequency users and targeted digital education for first-time buyers. At the same time, supply chains are being recalibrated to mitigate raw material volatility, support sustainable sourcing, and shorten time-to-shelf for seasonal demand spikes. Taken together, these transformative shifts are redefining how manufacturers and retailers approach portfolio design, marketing, and operational resilience.

Assessing the operational and commercial consequences of tariff adjustments in 2025 and the tactical responses firms are deploying to safeguard margin and supply continuity

Tariff policy changes in 2025 have created a layered set of implications for stakeholders across the mosquito repellent value chain, influencing sourcing choices, cost structures, and strategic planning. Increased duties on finished goods and certain raw material categories have prompted many suppliers to re-evaluate supplier networks and consider alternative sourcing hubs to preserve margin and maintain timely fulfilment. For companies with integrated manufacturing footprints, the immediate response has included rebalancing import volumes and advancing local production where feasible to minimize exposure to tariff volatility.

In addition, procurement teams have intensified scenario planning to quantify the operational impact of tariff-induced cost changes and to identify levers for mitigation. These responses often include renegotiating contracts, diversifying supplier bases, and investing in inventory buffers to smooth seasonal peaks. Importantly, shifts in trade policy have also pressured ingredient suppliers to improve transparency and traceability, as clients demand evidence of origin and tariff classifications that align with compliance requirements.

On the commercial front, some brands have chosen to absorb incremental costs to protect pricing-sensitive segments, while others have adjusted pricing architecture or introduced value-tiered SKUs to preserve margin and cater to different consumer willingness to pay. Looking ahead, continued monitoring of tariff regimes, paired with flexible sourcing strategies and agile pricing mechanisms, will be essential for companies aiming to sustain competitiveness and operational continuity in a shifting trade environment.

Deep segmentation analysis revealing how form, active ingredient origin, application method, and channel choices should shape product strategy and market approaches

Understanding segmentation is fundamental to shaping product development, marketing, and distribution strategies across the mosquito repellent category. Based on form, product development teams must consider the distinct user contexts for Coil, Gel, Lotion, Spray, and Vaporizer formats; each form factor implies different usage occasions, delivery durations, and regulatory labeling considerations, and as a result, segmentation decisions influence packaging design, dosing recommendations, and channel placement.

Turning to raw materials, companies face a strategic bifurcation between Chemically Derived Repellents and Plant-based Repellents. Within chemically derived options, DEET, IR3535, and Picaridin represent established actives with distinct efficacy profiles, skin compatibility considerations, and consumer perceptions that affect claim substantiation and education campaigns. Conversely, plant-based repellents such as Citronella, Eucalyptus, Lemon Grass, Neem Oil, and Peppermint Oil offer opportunities to capture consumers seeking natural positioning, yet they require rigorous performance validation and careful formulation to deliver consistency and shelf stability.

Application Method segmentation, spanning Non-Topical and Topical approaches, has practical implications for hygienic use, regulatory classification, and consumer preference. Non-topical solutions like ambient vaporizers and coils often address household protection contexts, whereas topical lotions, sprays, and gels cater to personal protection needs outdoors and during travel. Finally, distribution channel segmentation covers Offline and Online pathways, with Offline channels like Convenience Store, Pharmacy, and Supermarket providing high-frequency, impulse, and trust-driven purchase environments, and Online channels such as Company Website and eCommerce Platforms enabling subscription models, targeted messaging, and direct consumer engagement. Together, these segmentation lenses guide portfolio architecture, marketing mix, and supply chain prioritization to ensure alignment with targeted consumer cohorts and retail partners.

Regional strategic imperatives across the Americas, Europe, Middle East & Africa, and Asia-Pacific that determine product design, regulatory readiness, and channel activation

Regional dynamics present differentiated opportunities and operational considerations for stakeholders, shaped by climate patterns, regulatory regimes, and consumer behaviors across geographic markets. In the Americas, urbanization trends and high public health awareness drive demand for formulations that balance efficacy with convenience, supporting growth in topical sprays and long-duration lotions tailored for outdoor recreation and household use. Moreover, retail ecosystems in this region emphasize omnichannel availability, enabling brands to deploy promotions and educational campaigns that reinforce product efficacy and safety narratives.

In Europe, Middle East & Africa, regulatory scrutiny and varied climatic conditions create a complex operating environment. Stricter labeling and environmental standards in many European markets necessitate rigorous compliance processes and robust substantiation of claims, while certain markets in the Middle East & Africa prioritize sustained protection for both household and institutional use due to endemic vector-borne risks. This heterogeneity requires adaptive product portfolios that consider local regulatory frameworks, cultural preferences for certain scents or delivery systems, and distribution models that can reach both urban and remote consumers.

Asia-Pacific exhibits intense innovation and rapid adoption of novel formats, driven by high population densities, diverse usage contexts, and strong demand for plant-derived alternatives in some markets. Here, manufacturers often emphasize localized formulations and packaging sizes to match consumption patterns, and digital commerce plays a pivotal role in reaching younger, tech-savvy consumers. Across regions, companies that tailor product features, messaging, and channel strategies to regional specificities are best positioned to convert demand into sustained brand loyalty.

How legacy efficacy claims, nimble challenger brands, and strategic partnerships are redefining competitive advantage and shaping long-term value creation in the category

Competitive dynamics in the mosquito repellent space are shaped by a mix of legacy brands with established efficacy claims and newer entrants that emphasize natural ingredients or differentiated delivery systems. Leading companies maintain advantage through sustained investment in formulation R&D, clinical validation studies, and supply chain integration that secures reliable access to key actives and botanicals. At the same time, challenger brands are leveraging agile product development, direct-to-consumer distribution, and targeted social marketing to capture niche segments and accelerate awareness.

Partnerships between ingredient suppliers, contract manufacturers, and consumer brands are increasingly common, enabling faster time-to-market for innovations such as extended-release matrices, non-greasy topical forms, and low-odor ambient devices. These collaborations also support scale-up for new actives and help navigate regulatory filings across jurisdictions. In addition, private-label growth among retailers is introducing competitive pricing pressure, prompting brand owners to emphasize proprietary formulations, clinical data, and brand trust to maintain premium positioning.

Competitive advantage will increasingly depend on the ability to combine proven efficacy with differentiated consumer experiences, operational agility, and transparent communication. Firms that can demonstrate robust safety and performance data while delivering compelling sensory attributes and seamless purchasing journeys are likely to capture disproportionate share of consumer attention and loyalty.

Actionable strategic priorities for leaders to secure supply resilience, accelerate formulation innovation, and align channel strategies with consumer usage contexts

Industry leaders should prioritize a set of coordinated actions to translate insight into durable competitive advantage. First, invest in formulation innovation that balances efficacy with sensory acceptability and ingredient transparency; this includes validating plant-based actives where appropriate and enhancing delivery systems to extend protection while improving user experience. Second, build resilient sourcing strategies that diversify suppliers of both chemical actives and botanical inputs, paired with robust traceability frameworks to satisfy compliance and stakeholder expectations.

Third, adopt a channel-specific commercial approach that aligns product formats with purchase contexts-ensuring that coils and vaporizers receive strong in-store placement while sprays and lotions are supported by digital education and subscription fulfilment online. Fourth, strengthen claim substantiation and third-party validation to differentiate premium SKUs and reassure safety-conscious buyers. Fifth, develop agile pricing and packaging tiers to manage the impact of trade policy shifts while preserving accessibility for value-seeking consumers. Finally, embed cross-functional scenario planning to anticipate regulatory shifts and supply disruptions, fostering quicker decision cycles and coordinated responses across R&D, procurement, and commercial teams.

Taken together, these actions provide a framework for converting market intelligence into operational priorities that enhance resilience, accelerate innovation, and increase consumer trust.

A robust mixed-methods research design combining expert interviews, regulatory reviews, and analytical segmentation to underpin strategic conclusions and recommendations

This analysis draws on a multi-method research approach that combines primary stakeholder interviews, expert consultations, and systematic review of regulatory and patent activity to ensure a holistic understanding of the category. Primary inputs included structured discussions with formulation scientists, procurement leaders, retail category managers, and public health experts to capture operational realities, consumer drivers, and compliance considerations across markets. These insights were complemented by an examination of recent regulatory advisories and product registration trends to map current enforcement priorities and labeling expectations.

Secondary research supported thematic triangulation, drawing on academic literature related to active ingredient efficacy, consumer surveys on usage patterns, and trade publications that document distribution shifts and procurement practices. Analytical methods included segmentation mapping to align product form and application with consumer occasions, and scenario planning to evaluate exposure to tariff changes and supply chain disruptions. Throughout, emphasis was placed on evidence-backed conclusions and actionable implications rather than speculative projections, ensuring the findings are directly relevant to commercial and regulatory decision-making.

This methodology balances qualitative depth with cross-market perspective and provides a defensible foundation for strategic recommendations and product positioning choices.

Concluding synthesis that ties together innovation, regulatory vigilance, and consumer-centric strategies to build resilient, differentiated portfolios in the mosquito repellent category

In conclusion, the mosquito repellent category is at an inflection point where product innovation, consumer expectations, regulatory complexity, and trade dynamics converge to redefine competitive advantage. Success will hinge on an integrated approach that prioritizes proven performance, ingredient transparency, and tailored channel strategies while maintaining operational flexibility to respond to policy shifts and supply constraints. Brands that invest in rigorous validation of both chemical and plant-based solutions, and that align packaging and pricing to distinct usage contexts, will be better positioned to earn consumer trust and sustain growth.

Moreover, proactive engagement with regulatory developments and deliberate supply chain diversification will reduce exposure to tariff volatility and sudden input shortages. Equally important is a relentless focus on customer experience-ensuring that sensory attributes, convenience, and clear communication translate to repeat purchase and advocacy. By synthesizing these elements into a cohesive strategy, stakeholders can transform short-term challenges into long-term differentiation and resilience within a category that remains essential to public health and everyday consumer life.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Mosquito Repellent Market, by Form

• 8.1. Coil
• 8.2. Gel
• 8.3. Lotion
• 8.4. Spray
• 8.5. Vaporizer

9. Mosquito Repellent Market, by Raw Material

• 9.1. Chemically Derived Repellents
  • 9.1.1. DEET
  • 9.1.2. IR3535
  • 9.1.3. Picaridin
• 9.2. Plant-based Repellents
  • 9.2.1. Citronella
  • 9.2.2. Eucalyptus
  • 9.2.3. Lemon Grass
  • 9.2.4. Neem Oil
  • 9.2.5. Peppermint Oil

10. Mosquito Repellent Market, by Application Method

• 10.1. Non-Topical
• 10.2. Topical

11. Mosquito Repellent Market, by Distribution Channel

• 11.1. Offline
  • 11.1.1. Convenience Store
  • 11.1.2. Pharmacy
  • 11.1.3. Supermarket
• 11.2. Online
  • 11.2.1. Company Website
  • 11.2.2. eCommerce Platforms

12. Mosquito Repellent Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Mosquito Repellent Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Mosquito Repellent Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. United States Mosquito Repellent Market

16. China Mosquito Repellent Market

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025
• 17.5. 3M Company
• 17.6. Avon Products, Inc.
• 17.7. BASF SE
• 17.8. Bayer Aktiengesellschaft
• 17.9. Dabur India Limited
• 17.10. Dainihon Jochugiku Co., Ltd
• 17.11. EarthKind, LLC
• 17.12. Enesis Group
• 17.13. FMC Corporation
• 17.14. Godrej Consumer Products Limited
• 17.15. Jyothy Laboratories Limited
• 17.16. KIK Custom Products, Inc.
• 17.17. Lonza Group AG
• 17.18. Pic Corporation
• 17.19. Pif Paf Alimentos Source
• 17.20. Reckitt Benckiser Group plc
• 17.21. Sawyer Products
• 17.22. SC Johnson & Son, Inc.
• 17.23. Spectrum Brands Holdings, Inc.
• 17.24. Tender Corporation
• 17.25. The Coleman Company, Inc.
• 17.26. Zhongshan LANJU Daily Chemical Industrial Co., Ltd.